Introduction
Controls over cell cycle transitions influence the activities of cyclin‐dependent protein kinases (cdks). The cdks required for each transition are activated and inactivated sequentially as cells cycle between alternating S‐phases and mitoses. There is an interdependency between these cell cycle transitions that must be maintained to ensure genomic integrity and prevent changes in ploidy; i.e. S‐phase onset is dependent on the completion of the previous mitosis, and the onset of mitosis is dependent on the completion of the previous S‐phase (
Nurse, 1994). Further, as the fidelity of these events is absolutely crucial, a cell will not continue progression through the cell cycle when defects in its division programme are detected. The surveillance mechanisms which monitor the state of the cell, and are believed ultimately to influence cell cycle transitions either directly or indirectly through the timing of cdk activation, are known as checkpoints (
Hartwell and Weinert, 1989).
The transition from G
2 into mitosis requires activation of an archetypal cdk, p34
cdc2 (
Nurse, 1990). In the fission yeast
Schizosaccharomyces pombe, as in all eukaryotes, this requires association of p34
cdc2 with its regulatory B‐type cyclin subunit and phosphorylation on threonine 167 of p34
cdc2 by a constitutive activity known as cdk‐activating kinase (CAK). This potentially active complex is maintained in an inactive state by inhibitory phosphorylation in the active site of p34
cdc2 on tyrosine 15 (Y15) by
wee1‐ and
mik1‐encoded tyrosine kinases throughout the G
2 period. When conditions are appropriate for entry into mitosis, the inhibitory phosphorylation on Y15 is removed by the
cdc25‐encoded Y15 phosphatase, and mitosis is initiated rapidly. This activating modification is the rate‐limiting step for entry into mitosis.
During G
2, there are checkpoints which monitor completion of S‐phase and prevent mitosis in its absence, and which also monitor the integrity of the genome and act to prevent the onset of mitosis when damage is detected. Genetic studies in fission yeast have identified a number of checkpoint proteins which are required for either, or in most cases both, of these checkpoints (
Humphrey and Enoch, 1995). These proteins are non‐essential, and so act to alter cell cycle transitions only under conditions of stress. In some cases, the predicted amino acid sequences have given some clue as to their function, but in general we have little idea as to how these proteins function to elicit cell cycle arrest. Genetic studies so far have not been particularly illuminating, as the non‐essential nature of these genes has led in most part to the isolation of null alleles, which then fail to show interactions with each other. Similarly, it has also been difficult to build direct links between the checkpoint proteins and the core cell cycle regulators in response to G
2 checkpoint‐mediated signals. In the case of the DNA replication checkpoint, inhibitory Y15 phosphorylation has been shown to be the end‐point of this checkpoint, but what lies directly upstream is unknown (
Enoch and Nurse, 1990). With the G
2 DNA damage checkpoint, the involvement of p34
cdc2 Y15 phosphorylation is less clear. Cells lacking the major Y15 kinase encoded by
wee1, p107
wee1, delay cell cycle progression following DNA damage and yet are still hypersensitive to DNA‐damaging agents (
Barbet and Carr, 1993). Therefore, this delay may not represent a true checkpoint in that cell viability is not maintained. This is compounded further by the observation that
wee1− mutants are synthetically lethal with G
2 checkpoint mutants, indicating that these cells require a constitutively active checkpoint to maintain viability (
Al‐Khodairy et al., 1994). Although there have been no reports as to the effects of evoking the G
2 DNA damage checkpoint on Y15 phosphorylation in fission yeast, in mammalian cells it has been shown to correlate with cell cycle arrest following DNA damage in G
2 (
Kharbanda et al., 1994a). However, the kinase responsible for this is unknown, although possible candidates are the wee1 kinase and the src‐related kinase p53/p56
lyn (
Kharbanda et al., 1994b). Furthermore, in the G
1 DNA damage checkpoint, it has been shown through overexpression of a mutant cdk4 allele (Cdk4
F17) that cell cycle progression may in part be delayed through tyrosine phosphorylation of cdk4 (
Tereda et al., 1995), in addition to the well established mechanism acting through cdk2 inhibition by binding of the inhibitory protein p21
CIP1/WAF1 (
Dulic et al., 1994;
Macleod et al., 1995).
Given the confusion surrounding these issues, we chose to address the role of p34cdc2 Y15 phosphorylation in the fission yeast G2 DNA damage checkpoint. Our studies described here show that Y15 remains phosphorylated after cells sustain DNA damage in G2 even though they have passed beyond the point at which Y15 normally would be dephosphorylated. This suggests that evoking the checkpoint leads to a maintenance of G2 through maintaining p34cdc2 in its Y15‐phosphorylated state. To confirm that maintenance of Y15 phosphorylation is linked to activation of the checkpoint, we have used the gain‐of‐function phenotype caused by overexpression of one component of the G2 DNA damage checkpoint, chk1. This gene encodes a protein kinase, p56chk1, which appears to function downstream of the other identified checkpoint functions. We show here that p56chk1 elicits a cell cycle arrest in G2 that acts through p107wee1‐dependent Y15 phosphorylation of p34cdc2. Further, we show that p107wee1 is phosphorylated in cells arrested by chk1 overexpression or UV irradiation. Finally, we show that p56chk1 can phosphorylate p107wee1 directly in vitro, thus establishing a potentially direct link between the signal transduction cascade which makes up the G2 DNA damage checkpoint and a core cell cycle regulator.
Discussion
Although many proteins involved in eliciting a G2 cell cycle arrest in response to DNA damage have been identified, little is known about how they interact to send signals to the core cell cycle regulators. Further, we have not known what the ultimate effect of evoking this checkpoint is on the p34cdc2–cyclin B complexes. In this study we have described experiments which address both of these issues.
By Western blot analysis of extracts prepared from irradiated G
2 cells, we showed that p34
cdc2 is maintained in its inactive, Y15‐phosphorylated form. This was maintained in cells despite the fact that they had fulfilled the cell size and completion of S‐phase requirements for entry into mitosis. These experiments were performed at a radiation dose which causes little effect in terms of viability on wild‐type cells, which recover due to the transient cell cycle delay induced by the checkpoint. This delay is, however, not long enough to see a significant accumulation of high levels of the Y15‐phosphorylated form of p34
cdc2. These data are consistent with those described for mammalian cells which have correlated p34
cdc2 Y15 phosphorylation with DNA damage‐induced G
2 delay (
Kharbanda et al., 1994a). Furthermore, other groups have demonstrated recently that Y15 phosphorylation is crucial in the G
2 DNA checkpoints of
Aspergillus nidulans (
Ye et al., 1997) and fission yeast (N.Rhind and P.Russell, personal communication), and in a G
2 checkpoint resulting from irradiation of human cells in S–phase (
Jin et al., 1996).
In our experiments, the cells are already in G
2 when they suffer DNA damage, and so our data would indicate that, under these conditions, the checkpoint functions to hold the cells in G
2 and prevent the onset of mitosis whilst the DNA is repaired. This maintenance of p34
cdc2 inhibition by Y15 phosphorylation rather than induction of an additional arrest mechanism is in contrast to that described for vertebrate cells in G
1: here, the potentially active cdk2–cyclin E complexes are inhibited by induction of the p21 cdk inhibitor (
Harper et al., 1993;
Macleod et al., 1995). A role for inhibition of G
1 cdks by tyrosine phosphorylation in G
1 checkpoints has also been shown by mutation in cdk4 (
Tereda et al., 1995). Furthermore, cdc25 phosphatases acting in G
1 have the ability, when overproduced, to override G
1 checkpoints in cellular transformation (
Galaktionov et al., 1995). Thus, inhibition of cdks by tyrosine phosphorylation appears to be generally important in checkpoints responding to DNA damage.
Although we had shown that p34cdc2 Y15 phosphorylation is associated with G2 checkpoint arrest, we asked whether this was a result of activation of the checkpoint. To answer this question, we chose to investigate the effects of up‐regulation of the p56chk1 kinase by overexpression. This line of investigation was particularly useful as it allowed investigation of the cell cycle arrest phenotype as a constitutive event in the absence of DNA damage. From these experiments, we established that overexpression of chk1 also resulted in G2 cell cycle arrest with p34cdc2 inactivated by Y15 phosphorylation. Importantly, we established that this arrest mechanism functioned directly through wee1 rather than through another p34cdc2 inhibitory mechanism: in the absence of wee1, cells were completely non‐responsive to the effects of chk1 overexpression. The fact that these cells retained their wee phenotype rules out the possibility that p56chk1 could be acting alternatively through inhibition of p80cdc25, as this would suppress the effects of lacking p107wee1. Furthermore, interactions with wee alleles of cdc2 confirmed the requirement for wee1 in this arrest, and that this was at the level of p107wee1‐mediated p34cdc2 Y15 phosphorylation.
Through Western blot analysis, we showed that p107wee1 became hyperphosphorylated when cells were arrested by chk1 overexpression or UV‐induced DNA damage. Together with the genetic observations, these data strongly implicated p107wee1 as a direct target of p56chk1. Evidence for this model was gained by in vitro kinase assays using baculovirus‐expressed proteins, which showed that p56chk1 can phosphorylate p107wee1 directly on serine residues. Although these data strongly suggest that p56chk1 is phosphorylating p107wee1 directly in vivo, we do not have direct evidence for this. Due to the complexity of phosphorylation events on p107wee1, this issue can only be resolved by mapping the in vitro phosphorylation sites, and assessing the function of these by mutation studies in vivo. Such experiments are underway.
The phosphorylation of p107
wee1 by p56
chk1 did not affect its
in vitro Y15 kinase activity, despite the fact that p56
chk1 clearly affects both p107
wee1 and Y15 phosphorylation. These data should be compared with published work concerning the checkpoint function associated with fission yeast
rad24, which encodes a 14‐3‐3 protein (
Ford et al., 1994). Analysis of
chk1 overexpression has shown it to act downstream of all checkpoint mutants with the exception of
rad24. Strains deleted for
rad24 are only partially responsive to
chk1, becoming delayed but not arrested in cell cycle progression. Importantly, however,
rad24Δ cells exhibit a wee phenotype, and thus also have a defect in cell cycle progression accelerating them through G
2. These phenotypes could be related if
rad24Δ strains are defective in some aspect of p107
wee1 control, which in turn makes them less responsive to p56
chk1‐mediated signals. In view of these data, it is noteworthy that a physical interaction between murine homologues of p107
wee1 and 14‐3‐3 proteins have been observed
in vitro and
in vivo, without an effect on p107
wee1 activity (R.Honda and H.Yasuda, personal communication). Further, 14‐3‐3 proteins have been implicated in subcellular localization and protein–protein interactions (
Burbelo and Hall, 1995) through association with phosphoserine residues, which were the sites of phosphorylation of p107
wee1 by p56
chk1. Both the wee phenotype and insensitivity to
chk1 of
rad24Δ could, therefore, be a result of inappropriate localization or protein–protein interactions of p107
wee1 when the
rad24‐encoded 14‐3‐3 protein is not present, and not a result of alteration of its intrinsic kinase activity.
Based on the genetic and biochemical experiments performed in fission yeast, and the
in vitro phosphorylation experiments with recombinant protein, we propose a model for cell cycle arrest following DNA damage in G
2: as a consequence of DNA damage, p56
chk1 is activated and maintains p34
cdc2 Y15 phosphorylation by phosphorylating p107
wee1 (
Figure 7). This phosphorylation does not affect the
in vitro p107
wee1 kinase activity, but does affect the
in vivo function of p107
wee1, perhaps by affecting its intracellular localization, interaction with p34
cdc2 or interaction with negative regulatory proteins functioning at the G
2–M transition. This leads to the activity of p107
wee1 being maintained after genome damage beyond the point when an appropriate cell size is achieved and cells would normally enter mitosis. In vertebrates, a similar mechanism has been proposed for the DNA replication checkpoint (
McGowan and Russell, 1995). This checkpoint clearly functions through Y15 phosphorylation (
Enoch et al., 1992), but is not associated with an increase in p107
wee1 activity above that observed in normal G
2 cells (
McGowan and Russell, 1995;
Mueller et al., 1995). Although the DNA replication and DNA damage checkpoints have overlapping components, p56
chk1 is not involved in the replication checkpoint, suggesting that separable but overlapping pathways are involved in G
2 checkpoint controls. A good candidate for a protein carrying out an analogous function to p56
chk1 in the fission yeast DNA replication checkpoint is p52
cds1 (
Murakami and Okayama, 1995). This protein kinase is required for cell cycle delay following a block to DNA replication, but not following DNA damage. At this stage, we do not know the mechanism by which DNA damage is detected, or how this results in activation of p56
chk1. However, is has been shown that p56
chk1 becomes phosphorylated after DNA damage (
Walworth and Bernards, 1996), and this may play some role in its activation.
If p107
wee1 is a target of the G
2 DNA damage checkpoint, how can strains completely lacking
wee1 arrest in response to irradiation (
Barbet and Carr, 1993)? The answer to this is likely to lie in the redundancy of Y15 kinases in fission yeast (
Lundgren et al., 1991). We suggest that p107
wee1 is a target of the checkpoint, but not the only target. At least one other Y15 kinase, p66
mik1, is likely to play some role. The radiation sensitivity of
wee1Δ cells indicates that a
wee1‐independent arrest involving
mik1 is not sufficient to maintain wild‐type levels of viability after DNA damage. When both kinases are absent, all G
2 controls are lost and cells enter mitosis constitutively, leading to a lethal mitotic catastrophe phenotype. Although
wee1 and
mik1 have overlapping functions,
mik1Δ mutants do not exhibit a wee phenotype, suggesting that p66
mik1 plays a minor role in G
2 control in the presence of p107
wee1. It is also important to note that the viability of
wee1Δ cells, even when unirradiated, requires all known G
2 checkpoint functions, including
chk1 (
Al‐Khodairy et al., 1994), which may also act through
mik1 under these conditions. This indicates that checkpoint functions are constitutively active in these cells, and may act to up‐regulate p66
mik1 so as to prevent premature entry into mitosis. Our data show that Y15 phosphorylation plays a role in the G
2 DNA damage checkpoint functioning through p56
chk1, but we cannot rule out additional regulatory mechanisms.
The data presented here provide a direct link between a G2 checkpoint function and a core cell cycle regulator. This link establishes a firm basis on which to build this pathway, which although it has many identified members, still lacks the biochemical links required to understand this important biological phenomenon.